VerImmune

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$4.5M

VerImmune Inc. is a biotechnology company developing a novel cancer immunotherapy that redirects pre-existing immune memory towards tumors using their ViP™ platform technology.